The U.S. C-reactive protein (CRP) testing market is witnessing robust growth, valued at USD 769.66 million in 2024 and projected to reach USD 1,253.69 million by 2034, expanding at a CAGR of 5.02% from 2025 to 2034. The surge in diagnostic testing demand, increasing prevalence of cardiovascular and inflammatory diseases, and adoption of point-of-care (PoC) testing solutions are driving market expansion. CRP testing is widely used as a biomarker analysis tool to monitor disease progression, assess treatment effectiveness, and enable early intervention.
For detailed insights on market dynamics, competitive landscape, and growth opportunities, refer to the U.S. C-reactive protein testing market report.
Market Overview
CRP testing is a critical tool in preventive and personalized healthcare. The tests detect C-reactive protein levels in blood, which rise in response to inflammation, infection, or tissue injury. Increasing awareness among healthcare providers and patients about the importance of early diagnosis has led to significant adoption across hospitals, clinics, and diagnostic labs.
The market is witnessing innovations in rapid PoC devices, automated laboratory analyzers, and integrated health monitoring solutions, offering faster turnaround times and higher accuracy. Growing emphasis on preventive medicine and biomarker analysis is further enhancing CRP test utilization.
Market Segmentation
The U.S. CRP testing market is segmented based on test type, technology, application, end-user, and distribution channel.
By Test Type
- High-Sensitivity CRP (hs-CRP) – Primarily for cardiovascular risk evaluation.
- Standard CRP – Used for monitoring general infections and inflammatory disorders.
By Technology
- ELISA (Enzyme-Linked Immunosorbent Assay) – Laboratory standard, high accuracy.
- Immunoturbidimetric/Latex-Enhanced Assays – Rapid and suitable for automated analyzers.
- – Advanced techniques used in research and specialty labs.
- PoC Testing Devices – Compact, rapid-testing kits for clinics and emergency care.
By Application
- Cardiovascular Risk Assessment – hs-CRP tests for predicting heart attacks and strokes.
- Inflammatory Disease Monitoring – Rheumatoid arthritis, lupus, and autoimmune disorder detection.
- Infection Detection – Acute bacterial and viral infection monitoring.
- Other Applications – Research, post-operative monitoring, and wellness assessments.
By End-User
- Diagnostic Laboratories
- PoC Testing Centers
- Research Institutions
By Distribution Channel
- Medical Distributors
- Online Channels for PoC Test Kits
Regional Insights
The U.S. market exhibits significant regional adoption differences:
- Northeast – Advanced healthcare infrastructure and higher disease prevalence increase test adoption.
- Midwest – Growing PoC testing in rural hospitals improves access to CRP diagnostics.
- South – Rising incidence of cardiovascular conditions drives demand for hs-CRP testing.
- West Coast – Focus on technologically advanced analyzers and automated lab solutions.
Urban and suburban regions dominate due to better healthcare access and technology penetration.
Market Drivers
- Rising Chronic Disease Burden – High prevalence of heart disease, autoimmune conditions, and inflammatory disorders.
- Rapid Adoption of PoC Testing – Quick results in clinics, emergency rooms, and outpatient settings improve patient outcomes.
- – Physicians increasingly use CRP testing for early diagnosis and monitoring therapy response.
- Technological Advancements – Development of miniaturized PoC devices and automated laboratory analyzers.
- Integration in Personalized Medicine – CRP testing is essential for tailoring treatments to individual patients.
Market Challenges
- Cost considerations for PoC and high-sensitivity assays.
- Limited insurance coverage and reimbursement issues.
- Competition from other biomarkers like procalcitonin, IL-6, and ESR tests.
- Regulatory requirements impacting product approvals and market entry.
Competitive Landscape
Key participants are innovating to expand their market presence through .
Leading Companies:
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Beckman Coulter
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- BioMérieux
- Quidel Corporation
- Randox Laboratories
- DiaSorin
These companies focus on automated lab platforms, rapid PoC testing devices, and integration with electronic health records to enhance adoption.
Market Trends
- PoC Expansion – Rapid CRP testing kits in clinics, ERs, and outpatient centers.
- Automated Lab Systems – High-throughput CRP testing improving workflow efficiency.
- Digital Health Integration – Linking CRP data with electronic health records for continuous patient monitoring.
- Personalized Treatment Planning – CRP levels guiding medication and therapy choices.
Future Outlook
The U.S. CRP testing market is expected to grow steadily, supported by:
- Increasing adoption of PoC testing in outpatient and remote healthcare.
- Expansion of hs-CRP testing for cardiovascular risk screening.
- Integration of CRP testing in personalized and preventive medicine programs.
- Rising investments in advanced diagnostics and automated laboratory systems.
With the growing focus on healthcare efficiency, CRP testing is likely to become a standard component of routine health assessments.
Conclusion
The U.S. C-reactive protein testing market is projected to reach USD 1,253.69 million by 2034, with a CAGR of 5.02%. Growth will be driven by diagnostic testing, point-of-care testing, biomarker analysis, and inflammatory disease diagnostics. Increasing awareness of early disease detection, technological advancements, and integration into personalized healthcare solutions will continue to propel market expansion. For further updates, visit U.S. C-reactive protein testing.
More Trending Latest Reports By Polaris Market Research:
Internet Of Things (Iot) In Healthcare Market
Internet Of Things (Iot) In Healthcare Market
Automotive E-Compressor Market
